Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

NCT06905834 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye Disease (DED)
Graft-Versus-Host Disease(GVHD)

Interventions

DRUG: Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC

Sponsor

Instituto de Investigación Biomédica de Salamanca

Collaborators

[object Object]
[object Object]